| Original language | English |
|---|---|
| Pages (from-to) | 761-763 |
| Number of pages | 3 |
| Journal | Hepatology |
| Volume | 75 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Hepatology, Vol. 75, No. 3, 03.2022, p. 761-763.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Reply
AU - Ghany, Marc G.
AU - King, Wendy C.
AU - Lisker-Melman, Mauricio
AU - Lok, Anna S.F.
AU - Terrault, Norah
AU - Janssen, Harry L.A.
AU - Khalili, Mandana
AU - Chung, Raymond T.
AU - Lee, William M.
AU - Lau, Daryl T.Y.
AU - Cloherty, Gavin A.
AU - Sterling, Richard K.
N1 - Funding Information: ACKNOWLEDGMENTS The authors acknowledge the use of Hepatitis B Research Network (HBRN) samples and data as the sole contribution of the HBRN. The HBRN was funded as a Cooperative Agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the following investigators: Lewis R. Roberts, MB, ChB, PhD (U01-DK082843), Anna Suk-Fong Lok, MD (U01-DK082863), Steven H. Belle, PhD, MScHyg (U01-DK082864), Kyong-Mi Chang, MD (U01-DK082866), Michael W. Fried, MD (U01-DK082867), Adrian M. Di Bisceglie, MD (U01-DK082871), William M. Lee, MD (U01-DK082872), Harry L. A. Janssen, MD, PhD (U01-DK082874), Daryl T-Y Lau, MD, MPH (U01-DK082919), Richard K. Sterling, MD, MSc (U01-DK082923), Steven-Huy B. Han, MD (U01-DK082927), Robert C. Carithers, MD (U01-DK082943), and Mandana Khalili, MD (U01-DK082944); an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK- 3002- 001); and support from the intramural program, NIDDK, National Institues of Health (NIH): Marc G. Ghany, MD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01-RR00040), Richard K. Sterling, MD, MSc (UL1TR000058, National Center for Advancing Translational Sciences, NIH), Mandana Khalili, MD, MAS (CTSA UL1TR000004), Michael W. Fried, MD (CTSA UL1TR001111), and Anna Suk-Fong Lok (CTSA UL1RR024986 and U54TR001959.) Additional support was provided by Gilead Sciences, Inc., and Roche Molecular Systems via a CRADA through the NIDDK. Funding Information: The authors acknowledge the use of Hepatitis B Research Network (HBRN) samples and data as the sole contribution of the HBRN. The HBRN was funded as a Cooperative Agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the following investigators: Lewis R. Roberts, MB, ChB, PhD (U01‐DK082843), Anna Suk‐Fong Lok, MD (U01‐DK082863), Steven H. Belle, PhD, MScHyg (U01‐DK082864), Kyong‐Mi Chang, MD (U01‐DK082866), Michael W. Fried, MD (U01‐DK082867), Adrian M. Di Bisceglie, MD (U01‐DK082871), William M. Lee, MD (U01‐DK082872), Harry L. A. Janssen, MD, PhD (U01‐DK082874), Daryl T‐Y Lau, MD, MPH (U01‐DK082919), Richard K. Sterling, MD, MSc (U01‐DK082923), Steven‐Huy B. Han, MD (U01‐DK082927), Robert C. Carithers, MD (U01‐DK082943), and Mandana Khalili, MD (U01‐DK082944); an interagency agreement with NIDDK: Lilia M. Ganova‐Raeva, PhD (A‐DK‐3002‐001); and support from the intramural program, NIDDK, National Institues of Health (NIH): Marc G. Ghany, MD. Additional funding to support this study was provided to Kyong‐Mi Chang, MD, the Immunology Center (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01‐RR00040), Richard K. Sterling, MD, MSc (UL1TR000058, National Center for Advancing Translational Sciences, NIH), Mandana Khalili, MD, MAS (CTSA UL1TR000004), Michael W. Fried, MD (CTSA UL1TR001111), and Anna Suk‐Fong Lok (CTSA UL1RR024986 and U54TR001959.) Additional support was provided by Gilead Sciences, Inc., and Roche Molecular Systems via a CRADA through the NIDDK.
PY - 2022/3
Y1 - 2022/3
UR - https://www.scopus.com/pages/publications/85121444001
U2 - 10.1002/hep.32251
DO - 10.1002/hep.32251
M3 - Letter
C2 - 34800047
AN - SCOPUS:85121444001
SN - 0270-9139
VL - 75
SP - 761
EP - 763
JO - Hepatology
JF - Hepatology
IS - 3
ER -